Olympus president Takayama at press conference

Olympus president Takayama at press conference

TOKYO, Japan - Olympus Corp. President Shuichi Takayama gives a press conference in Tokyo on Nov. 8, 2011. Takayama apologized for his company's failure to book its past losses and said it is considering filing a criminal complaint against former president Tsuyoshi Kikukawa and other officials in connection with the issue.

  • Product Code
  • ILEA001164154
  • Registered date
  • 2011/11/08 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • 2011 Kyodo News
  • Media size
  • 1303 × 1864 pixel
  • Resolution
  • 240 dpi
  • Deployment size
  • 533.67(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    New coronavirus

    New coronavirus

    Officials of Japan's health ministry hold a press conference on Feb. 6, 2020, in Tokyo on the situation regarding the new coronavirus. (Kyodo) ==Kyodo
      Avigan could be formally approved as Ebola drug early 2015

      Avigan could be formally approved as Ebola drug early 2015

      TOKYO, Japan - Shigetaka Komori, chief executive officer of Fujifilm Holdings Corp., attends a press conference in Tokyo, Japan, on Nov. 11, 2014, announcing that the company expects its Avigan anti-influenza drug to be formally approved early next year for treating people infected with the Ebola virus.
        Hospital succeeds in heart surgery on 2-month-old boy

        Hospital succeeds in heart surgery on 2-month-old boy

        MATSUE, Japan - Yoshifumi Fujimoto (R), a heart surgeon at Shimane University Hospital, attends a press conference on Oct. 8, 2014, in the western Japan city of Izumo. The hospital team successfully performed arterial switch operations on the heart of a 2-month-old baby who was suffering from a serious congenital heart disease.
          Research to start on blood tests to detect 13 cancer types

          Research to start on blood tests to detect 13 cancer types

          TOKYO, Japan - Researchers announce the commencement of a project to develop ways of detecting 13 types of cancer from a single blood sample at a press conference in Tokyo on Aug. 18, 2014. Making the announcement were Kenji Kurata (L), president of the New Energy and Industrial Technology Development Organization, Tomomitsu Hotta (C), president of the National Cancer Center, and Tetsu Yonehara, head of Toray Industries Inc.'s New Frontiers Research Laboratories.
            Novartis management replaced

            Novartis management replaced

            TOKYO, Japan - David Epstein (L), president of Swiss pharmaceutical giant Novartis speaks during a press conference in Tokyo on April 3, 2014. The Japanese sales arm of the company, Novartis Pharma K.K., announced that its president, Yoshiyasu Ninomiya, and two other top executives have resigned to take responsibility for its employees' inappropriate involvement in a clinical study led by medical doctors. At right is new Novartis Pharma K.K. President Dirk Kosche.
              Novartis management replaced

              Novartis management replaced

              TOKYO, Japan - David Epstein, president of Swiss pharmaceutical giant Novartis holds a press conference in Tokyo on April 3, 2014. The Japanese sales arm of the company, Novartis Pharma K.K., announced that its president, Yoshiyasu Ninomiya, and two other top executives have resigned to take responsibility for its employees' inappropriate involvement in a clinical study led by medical doctors.
                Novartis management replaced

                Novartis management replaced

                TOKYO, Japan - Dirk Kosche, new president of Novartis Pharma K.K., speaks during a press conference in Tokyo on April 3, 2014. The Japanese sales arm of Swiss pharmaceutical giant Novartis announced that its president, Yoshiyasu Ninomiya, and two other top executives have resigned to take responsibility for its employees' inappropriate involvement in a clinical study led by medical doctors.
                  Prosecutors charge ex-Tokyo Gov. Inose

                  Prosecutors charge ex-Tokyo Gov. Inose

                  TOKYO, Japan - Naoki Inose, the former governor of Tokyo, holds a press conference in the capital on March 28, 2014, after prosecutors filed criminal charges against him over his receipt of 50 million yen from major hospital chain Tokushukai. Inose violated the public offices election law as he failed to report the money to the Tokyo metropolitan government's electoral management committee in the December 2012 gubernatorial election.
                    Prosecutors charge ex-Tokyo Gov. Inose

                    Prosecutors charge ex-Tokyo Gov. Inose

                    TOKYO, Japan - Naoki Inose, the former governor of Tokyo, apologizes during a press conference in the capital on March 28, 2014, after prosecutors filed criminal charges against him over his receipt of 50 million yen from major hospital chain Tokushukai. Inose violated the public offices election law as he failed to report the money to the Tokyo metropolitan government's electoral management committee in the December 2012 gubernatorial election.
                      Takeda chief apologizes over data misuse in drug ad

                      Takeda chief apologizes over data misuse in drug ad

                      TOKYO, Japan - Takeda Pharmaceutical Co. President Yasuchika Hasegawa apologizes during a press conference in Tokyo on March 3, 2014, over an advertisement for the company's blood pressure-lowering drug that made it appear the product is more powerful in suppressing diseases than other medicines.